Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist

NCT01914757 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2508

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

BIOLOGICAL: Benralizumab
BIOLOGICAL: Placebo

Sponsor

AstraZeneca